期刊
CURRENT EYE RESEARCH
卷 34, 期 3, 页码 241-249出版社
TAYLOR & FRANCIS INC
DOI: 10.1080/02713680802714066
关键词
adenovirus; antimicrobial peptide; azurocidin; CAP37; herpes simplex virus
资金
- NIH [EY08227, EY08098, AI28018, EY015534]
- The Eye and Ear Foundation of Pittsburgh, Research to Prevent Blindness
- Oklahoma Center for the Advancement of Science and Technology
- NATIONAL EYE INSTITUTE [R01EY015534, R01EY008227, P30EY008098] Funding Source: NIH RePORTER
- NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI028018] Funding Source: NIH RePORTER
Purpose: The antiviral activity of an established antibacterial CAP37 domain and its extracellular mechanism of action were investigated. Methods: CAP37-derived peptides modified to assess the importance of disulfide bonds were evaluated in cytotoxicity and antiviral assays (direct time kill, dose dependency, and TOTO-1) for adenovirus (Ad) and herpes simplex virus type 1 (HSV-1). Results: Variable virus, adenovirus serotype-dependent, and dose-dependent inhibition were demonstrated without cytotoxicity. For peptide A (CAP3720-44), TOTO-1 dye uptake was demonstrated for Ad5 and HSV-1. Conclusions: Unlike the antibacterial activity of this CAP37 domain, its antiviral activity is not fully dependent upon disulfide bond formation. Viral inhibition appears to result, in part, from disruption of the envelope and/or capsid.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据